Company intelligence / Profile preview

LUMICKS

Amsterdam, North Holland, Netherlandslumicks.com ↗

Ownership: Private
Employees: ~273
Development stage: Commercial

Overview

LUMICKS develops and commercializes advanced life science instruments that enable real-time analysis of molecular and cellular mechanisms. Their technologies are used in academic and pharmaceutical R&D to accelerate drug discovery, particularly in immuno-oncology and cell therapy fields. The company’s z-Movi system has demonstrated utility in rapidly ranking CAR T-cell candidates by functional avidity. Their products are for Research Use Only. No clinical results as they do not develop therapeutics directly.

Modalities: Device (research instruments for single-molecule and cell avidity analysis)
Industry: Drug Discovery Services

Partnerships

Leucid Bio – collaboration to evaluate next-generation CAR T-cells using z-Movi® analyzer

Beyond the preview

Go deeper on LUMICKS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LUMICKS.

Explore the full profile